RCUS News and Press, Arcus Biosciences Inc. From 02/21/24

2024-02-21 17:57:25 ET More on Arcus Biosciences Arcus Biosciences: Showing There Might Be Something To TIGIT After All Arcus Biosciences: Did Gilead Sciences overpay for its latest investment? Arcus shares extend gains amid mixed reactions on Gilead stake purchase ...

Arcus and Gilead announced an additional equity investment of $320 million into Arcus and modifications to their domvanalimab + zimberelimab clinical program to focus on the highest unmet medical needs and largest market opportunities Pharmacokinetic (PK), pharmacodynamic (PD), safety and...

Vimeo Inc. (VMEO) is expected to report $-0.01 for Q4 2023 Heineken N.V ADR (HEINY) is expected to report for Q4 2023 American States Water Company (AWR) is expected to report $0.53 for Q4 2023 NextPlay Technologies Inc. (NXTP) is expected to report for Q3 2024 Inseego Corp. (INSG...

2024-02-20 17:20:59 ET More on Arcus Biosciences Arcus Biosciences: Showing There Might Be Something To TIGIT After All Arcus Biosciences: Did Gilead Sciences overpay for its latest investment? Arcus shares extend gains amid mixed reactions on Gilead stake purchase ...

2024-02-12 06:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will host a conference call and webcast on Wednesday, February 21, 2024 at 2:00 PM ...

2024-01-30 13:18:21 ET Earlier this week, Gilead Sciences ( NASDAQ: GILD ) raised its stake in Arcus Arcus Biosciences ( NYSE: RCUS ) to 33% from ~20% by making an additional equity investment of ~$320 million. The new share purchase came priced $21/share, compared to the $1...

2024-01-30 11:14:18 ET More on Gilead Sciences Gilead Sciences, Inc. (GILD) JPMorgan 42nd Annual Healthcare Conference (Transcript) Gilead's Dividend Growth Potential Looks Phenomenal Without A Clear Growth Path, Gilead Sciences Is A Hold Arcus shares extend ...

2024-01-30 10:22:11 ET More on Arcus Biosciences Arcus Biosciences: Showing There Might Be Something To TIGIT After All Arcus Biosciences' Oncology Odyssey: The Domvanalimab Journey Arcus Biosciences, Inc. (RCUS) Q3 2023 Earnings Call Transcript Gilead invest...

2024-01-30 08:39:01 ET Iterum Therapeutics  ( ITRM ) +61% Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections. Kura Oncology  ( KURA ) +16% Reports Positive Preliminary Ziftomen...